CFTR inhibitors (IOWH/Novartis)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCFTR inhibitors (IOWH/Novartis)
Drug Alias NameCFTR inhibitors (The Institute for OneWorld Health/Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator inhibitors
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsDiarrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute for OneWorld Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Institutes For Biomedical Research IncInstitute for OneWorld Health
Active IndicationsN/A
Inactive IndicationsDiarrhea

Other Information

ATC CodeN/A
Related LinksN/A